ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $406,000 | -19.1% | 19,549 | -40.5% | 0.01% | -30.0% |
| Q2 2018 | $502,000 | -24.7% | 32,849 | +10.6% | 0.01% | -28.6% |
| Q1 2018 | $667,000 | -25.1% | 29,699 | +0.3% | 0.01% | -26.3% |
| Q4 2017 | $891,000 | -15.8% | 29,599 | +5.4% | 0.02% | -9.5% |
| Q3 2017 | $1,058,000 | +39.6% | 28,091 | +3.3% | 0.02% | +23.5% |
| Q2 2017 | $758,000 | -24.2% | 27,191 | -6.5% | 0.02% | -29.2% |
| Q1 2017 | $1,000,000 | +22.0% | 29,091 | +2.3% | 0.02% | +26.3% |
| Q4 2016 | $820,000 | +5025.0% | 28,450 | +5590.0% | 0.02% | – |
| Q2 2016 | $16,000 | +23.1% | 500 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |